Cart
sales@molnova.com
Neuropeptide AF (hNPAF), Human
CAS No. ———
Neuropeptide AF (hNPAF), Human( ——— )
Catalog No. M41453 CAS No. ———
Neuropeptide AF (hNPAF), Human
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 25MG | Get Quote | Get Quote |
|
| 50MG | Get Quote | Get Quote |
|
| 100MG | Get Quote | Get Quote |
|
| 200MG | Get Quote | Get Quote |
|
| 500MG | Get Quote | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameNeuropeptide AF (hNPAF), Human
-
NoteResearch use only, not for human use.
-
Brief DescriptionNeuropeptide AF (hNPAF), Human
-
DescriptionNeuropeptide AF (hNPAF), Human
-
In Vitro———
-
In Vivo———
-
Synonyms———
-
PathwayOthers
-
TargetOther Targets
-
Recptor———
-
Research Area———
-
Indication———
Chemical Information
-
CAS Number———
-
Formula Weight1978.21
-
Molecular FormulaC90H132N26O25
-
Purity>98% (HPLC)
-
Solubility———
-
SMILES———
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
molnova catalog
related products
-
GSK-1520489A
GSK-1520489A is an active PKMYT1 inhibitor.
-
Insulin B (22-25)
Insulin B (22-25)
-
Somatostatin-28 a
Somatostatin-28 (sheep, human rat mouse) is a biologically active polypeptide, synthesised in the proximal intestinal epithelial cells. Somatostatin-28 (sheep, human rat mouse) suppresses glucose-stimulated insulin secretion without affecting circulating basal insulin concentration. Somatostatin-28 (sheep, human rat mouse) also targets to somatostatin receptor subtype 5 (SSTR5) to regulate GLP-1 secretion.
